Searched for
ASTRAZANECA
New study finds slightly increased rates of vein blood clots after AstraZaneca Covid vaccine; stresses risk of adverse events lowThe findings are based on 280,000 people aged 18-65 who received a first dose of the Oxford-AstraZeneca vaccine.- US export curbs can limit COVID-19 vaccine production, availability: SII CEO Adar PoonawallaSII, the world's biggest vaccine maker, has licensed the AstraZeneca/Oxford University product and will soon start bulk-manufacturing the N...
- India will be in a position to roll out vaccines once the licensure comes: VK PaulThere is no pressure on India’s regulator to take decision on the grant of market authorisation to the potential Covid-19 vaccine one way o...
- Swedish companies committing a fresh 1.1 billion dollars investment in IndiaGronblad was speaking on the sidelines of CEO Meet with Prime Minister Narendra Modi on a day when India and Sweden signed joint declaratio...
- Sun Pharma withdraws lawsuit filed by Ranbaxy against USFDAThe lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US, it added.
- Ranbaxy loses approvals, exclusivity of two drugs in USIn November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US.
Load More